文献速递乳腺乳腺X线

非钙化标本病理对立体定向真空辅助乳腺活检诊断为扁平上皮异型或非典型导管增生可疑钙化不完全取出时恶性低估的影响

Impact of Non-Calcified Specimen Pathology on the Underestimation of Malignancy for the Incomplete Retrieval of Suspicious Calcifications Diagnosed as Flat Epithelial Atypia or Atypical Ductal Hyperplasia by Stereotactic Vacuum-Assisted Breast Biopsy.
PubMed 文献 · Korean J Radiol · 2020-07-22

回顾性分析2010年1月至2016年12月1147例无肿块可疑钙化的立体定向真空辅助乳腺活检,其中46例(4.0%)扁平上皮异型和52例(4.5%)非典型导管增生因残留钙化行手术切除。17例(17.3%)升级为恶性;钙化范围>34.5 mm与恶性低估相关(OR=6.059,p=0.026);按钙化与非钙化标本病理分四组,D组(扁平上皮异型vs非高危病变)低估率最低(3.6%)。作者认为除扁平上皮异型合并非典型病变的非钙化标本外,扁平上皮异型或非典型导管增生诊断后需手术切除。

要点

  • 钙化范围>34.5 mm与恶性低估相关(OR=6.059,p=0.026)。
  • 非钙化标本无高危病变的扁平上皮异型组恶性低估率最低(3.6%)。
  • 非典型导管增生合并非钙化标本高危病变组恶性低估率最高(35.0%)。

临床应用与阅片要点

  • 作者认为钙化范围和非钙化标本病理可能有助于判断恶性低估的可能性。
  • 作者认为除扁平上皮异型合并非钙化标本无高危病变外,真空辅助活检诊断扁平上皮异型或非典型导管增生后需手术切除。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: Stereotactic vacuum-assisted breast biopsy (VABB) is considered a reliable alternative to surgical biopsy for suspicious calcifications. In most cases, the management of flat epithelial atypia (FEA) and atypical ductal hyperplasia (ADH) after VABB with residual calcifications requires surgical excision. This study aimed to evaluate the impact of pathology of non-calcified specimens on the underestimation of malignancy.

MATERIALS AND METHODS: We retrospectively reviewed 1147 consecutive cases of stereotactic VABB of suspicious calcifications without mass from January 2010 to December 2016 and identified 46 (4.0%) FEA and 52 (4.5%) ADH cases that were surgically excised for the retrieval of residual calcifications. Mammographic features and pathology of the calcified and non-calcified specimens were reviewed.

RESULTS: Seventeen specimens (17.3%) were upgraded to malignancy. Mammographic features associated with the underestimation of malignancy were calcification extent (> 34.5 mm: odds ratio = 6.059, p = 0.026). According to the pathology of calcified versus non-calcified specimens, four risk groups were identified: Group A (ADH vs. high-risk lesions), Group B (ADH vs. non-high-risk lesions), Group C (FEA vs. high-risk lesions), and Group D (FEA vs. non-high-risk lesions). The lowest underestimation rate was observed in Group D (Group A vs. Group B vs. Group C vs. Group D: 35.0% vs. 20.0% vs. 15.0% vs. 3.6%, p = 0.041, respectively).

CONCLUSION: Considering that the calcification extent and pathology of non-calcified specimens may be beneficial in determining the likelihood of malignancy underestimation, excision after FEA or ADH diagnosis by VABB is required, except for the diagnoses of FEA coexisting without atypia lesions in non-calcified specimens.

来源:Korean J Radiol,查看原文。版权归原作者所有。

引用

  1. Yu CC, Cheung YC, Ueng SH, et al. Impact of Non-Calcified Specimen Pathology on the Underestimation of Malignancy for the Incomplete Retrieval of Suspicious Calcifications Diagnosed as Flat Epithelial Atypia or Atypical Ductal Hyperplasia by Stereotactic Vacuum-Assisted Breast Biopsy. Korean J Radiol. 2020. PMID: 32729266. doi:10.3348/kjr.2019.0786

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。